General Notices

• Notice of Pre-application Webinar for NCI Funding Opportunity Announcement for RFA-CA-22-027 Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)"
  (NOT-CA-22-087)
  National Cancer Institute
  

Notice of Changes to Funding Opportunities

• Notice to update Scored Review Criteria for PAR-22-108 "Innovative Ways to Provide Education on Antimicrobial Stewardship Practices in Animals (U01) Clinical Trial Not Allowed"
  (NOT-FD-22-010)
  Food and Drug Administration
  

• Notice of Change in Application Due Date for RFA-HL-21-013 "Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)"
  (NOT-HL-22-023)
  National Heart, Lung, and Blood Institute
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Molecular Dynamics of HIV (R01 Clinical Trial Not Allowed)
  (NOT-AI-22-051)
  National Institute of Allergy and Infectious Diseases
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Ruth L. Kirschstein National Research Service Award (NRSA) Fellowship Awards to Support Training in Research Related to Down Syndrome as Part of the INCLUDE Project
  (NOT-OD-22-126)
  Office of the Director, NIH
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Neurological Disorders and Stroke
  

Funding Opportunities

• Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required)
  (RFA-DA-23-008)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 12, 2024
  
  

• Expanding Prevention Strategies for Mental Disorders in Mobile Populations in Humanitarian Crises (R34 Clinical Trial Optional)
  (RFA-MH-22-180)
  National Institute of Mental Health
  Application Receipt Date(s): October 25, 2022
  
  

• NINDS Interdisciplinary Team Science Grant (RM1 Clinical Trial Optional)
  (RFA-NS-22-036)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): October 08, 2024
  
  

• Treatments for Lewy Body Dementias and Frontotemporal Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required)
  (RFA-NS-22-056)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): November 21, 2022
  
  

• Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed)
  (RFA-NS-22-066)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): July 28, 2022